ArticleScientific reports2020

Infliximab concentrations in two non-switching cohorts of patients with inflammatory bowel disease: originator vs. biosimilar.

Ana Martínez-Feito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.